Pharmacology, Toxicology and Pharmaceutical Science
1,2-Dimethylhydrazine
60%
Abdominal Cancer
33%
Aberrant Crypt Foci
20%
Adhesive Agent
20%
Adverse Outcome
66%
Andrographolide
100%
Antibacterial Activity
20%
Antiinfective Agent
23%
Apis mellifera
22%
Bite
66%
Cerebrovascular Accident
33%
Cetuximab
100%
Chitosan
100%
Chitosan Nanoparticle
33%
Colon Carcinoma
20%
Colorectal Carcinoma
100%
Comorbidity
18%
Cross-Sectional Study
66%
Cytotoxicity
33%
Diabetes Mellitus
51%
Dyslipidemia
70%
Epidermal Growth Factor Receptor
13%
Guava
33%
Imidazole
22%
Imidazole Derivative
66%
Intraperitoneal Injection
66%
Ionizing Radiation
66%
Malignant Neoplasm
43%
Nanocarrier
20%
Nanoparticle
100%
Neurologic Disease
66%
Non Small Cell Lung Cancer
66%
Pectin
33%
Pentadecanoic Acid
13%
Polysaccharide
66%
Prospective Cohort Study
33%
Radiation Exposure
66%
Receptor
20%
Reinfection
33%
Rhesus E Antibody
13%
Rosuvastatin
22%
Scanning Electron Microscopy
20%
Sirtuin 6
66%
Stomach Lesion
33%
Styrofoam
13%
Synapsin I
66%
Transcription Factor Nrf2
66%
Treatment Group
40%
Triple Negative Breast Cancer
33%
Urinary Tract Infection
33%
Medicine and Dentistry
Abdominal Cancer
33%
Abdominal Pain
16%
Acetic Acid
22%
Adverse Outcome
66%
Alirocumab
16%
Anthocyanin
16%
Antioxidant
29%
Awareness
66%
Bite
22%
Cancer Growth
14%
COVID-19
33%
Cross Sectional Study
66%
Diabetes
52%
Diabetes Mellitus
39%
Dysbiosis
13%
Epileptic Seizure
44%
Evolocumab
16%
First Aid
66%
Gut
33%
Gut Microbiota
20%
Homeostasis
22%
Human Study
33%
Imidazole
22%
Imidazole Derivative
66%
Isoprenaline
16%
Lung Cancer Cell Line
66%
Maturity Onset Diabetes of the Young
41%
Medical History
16%
Morphology
14%
Mouth
22%
Neurologic Disease
22%
Non Small Cell Lung Cancer
66%
Orphan Disorder
16%
Portal Hypertension
16%
Prospective Cohort Study
33%
Public Health
9%
Quality of Life
33%
Reactive Oxygen Species
22%
Redox Signalling
14%
Rosuvastatin
16%
Roux-en-Y Gastric Bypass
16%
SIRT6
44%
Sirtuin 6
66%
Small Intestine Obstruction
16%
Stomach Lesion
33%
Sulfhemoglobinemia
16%
Synapsin I
66%
Tongue
22%
Transcription Factor Nrf2
66%
Vagus Nerve Stimulation
22%